These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6409059)

  • 1. Influence of hemodialysis on plasma chemotactic activity and the chemotactic responsiveness of polymorphonuclear neutrophils.
    Wierusz-Wysocka B; Wysocki H; Czarnecki R; Siekierka H; Baczyk K; Wysocki K
    Artif Organs; 1983 May; 7(2):159-62. PubMed ID: 6409059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine peripheral blood polymorphonuclear neutrophil chemotactic response to Pasteurella haemolytica or zymosan-activated serum.
    Bruecker KA; Schwartz LW
    Am J Vet Res; 1982 Oct; 43(10):1879-81. PubMed ID: 7149395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density changes in leukocytes following hemodialysis or exposure to chemotactic factors.
    Lewis SL; Van Epps DE; Chenoweth DE
    Am J Nephrol; 1986; 6(1):34-41. PubMed ID: 3963057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hemodialysis on neutrophil chemotactic responsiveness.
    Greene WH; Ray C; Mauer SM; Quie PG
    J Lab Clin Med; 1976 Dec; 88(6):971-4. PubMed ID: 993648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neutrophil function of uremic patients treated by hemodialysis or CAPD.
    Huttunen K; Lampainen E; Silvennoinen-Kassinen S; Tiilikainen A
    Scand J Urol Nephrol; 1984; 18(2):167-72. PubMed ID: 6463600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface membrane enzyme, chemotactic peptide binding activities, and chemotactic responsiveness of rabbit peripheral and peritoneal neutrophils.
    Tsung PK; Showell HJ; Becker EL
    Inflammation; 1980 Sep; 4(3):271-7. PubMed ID: 7429607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of recombinant human erythropoietin therapy on in vivo chemotaxis and in vitro phagocytosis of polymorphonuclear cells of hemodialysis patients.
    Sperschneider H; Neumann K; Ruffert K; Stein G
    Blood Purif; 1996; 14(2):157-64. PubMed ID: 8785031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of selected variables in the under-agarose assay for chemotactic responses of canine neutrophils.
    Nagahata H; Kociba GJ; Reiter JA; Couto CG
    Am J Vet Res; 1991 Jun; 52(6):965-9. PubMed ID: 1883103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hemodialysis on neutrophil chemotactic responsiveness.
    Björkstén B; Mauer SM; Mills EL; Quie PG
    Acta Med Scand; 1978; 203(1-2):67-70. PubMed ID: 626114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular degranulation of polymorphonuclear neutrophils during hemodialysis. The effects of pretreatment with colchicine.
    Wysocki H; Czarnecki R; Wierusz-Wysocka B; Siekierka H; Baczyk K
    Int J Artif Organs; 1985 Jan; 8(1):37-42. PubMed ID: 3972462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients.
    Rao M; Guo D; Jaber BL; Sundaram S; Cendoroglo M; King AJ; Pereira BJ; Balakrishnan VS;
    Kidney Int; 2004 Feb; 65(2):682-91. PubMed ID: 14717942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic factors for bovine leukocytes.
    Carroll EJ; Mueller R; Panico L
    Am J Vet Res; 1982 Sep; 43(9):1661-4. PubMed ID: 6816108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of chemotactic factors in serum and wound fluid by dextranomer.
    Oredsson SU; Gottrup F; Beckmann A; Hohn DC
    Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leucocyte chemotaxis in patients treated with chronic haemodialysis (author's transl)].
    Gómez Agudo G; Bernal Pérez M; Cuesta Muñoz J; Franco Alcalde L
    Med Clin (Barc); 1981 Jun; 77(2):60-3. PubMed ID: 7321627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone.
    Kurihara A; Ojima F; Tsurufuji S
    Biochem Biophys Res Commun; 1984 Mar; 119(2):720-5. PubMed ID: 6712653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.